⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BDRX News
Biodexa Pharmaceuticals plc American Depositary Shs
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
globenewswire.com
BDRX
Postponement and Re-scheduling of Annual General Meeting
globenewswire.com
BDRX
Biodexa issues letter to Shareholders
globenewswire.com
BDRX
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
globenewswire.com
BDRX
Tanner Pharma Group en Biodexa lanceren wereldwijd programma voor vroegtijdige toegang voor FAP-patiënten
businesswire.com
BDRX
Tanner Pharma Group e Biodexa lanciano il programma globale di accesso anticipato per i pazienti affetti da FAP
businesswire.com
BDRX
Tanner Pharma Group y Biodexa lanzan un programa de acceso anticipado global para pacientes de poliposis adenomatosa familiar
businesswire.com
BDRX
Tanner Pharma Group et Biodexa lancent un programme mondial d’accès anticipé destiné aux patients atteints de polypose adénomateuse familiale
businesswire.com
BDRX
Tanner Pharma Group und Biodexa starten globales Early-Access-Programm für FAP-Patienten
businesswire.com
BDRX
Preliminary Results for the Year Ended 31 December 2025
globenewswire.com
BDRX
PFE